China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294) for CNY 260 million on September 26, 2023. China Resources Double-Crane Pharmaceutical Co.,Ltd. entered into an agreement to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd on September 27, 2023.